These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 24976227)
1. Perineural invasion in prostate cancer patients who are potential candidates for active surveillance: validation study. Trpkov C; Yilmaz A; Trpkov K Urology; 2014 Jul; 84(1):149-52. PubMed ID: 24976227 [TBL] [Abstract][Full Text] [Related]
2. Perineural invasion on prostate biopsy does not predict adverse pathological outcome. Elharram M; Margel D; Finelli A; Trachtenberg J; Evans A; van der Kwast TH; Sweet JM; Fleshner N Can J Urol; 2012 Dec; 19(6):6567-72. PubMed ID: 23228294 [TBL] [Abstract][Full Text] [Related]
3. Biopsy Perineural Invasion in Prostate Cancer Patients Who Are Candidates for Active Surveillance by Strict and Expanded Criteria. Turner RM; Yecies TS; Yabes JG; Ristau BT; Woldemichael E; Davies BJ; Jacobs BL; Nelson JB Urology; 2017 Apr; 102():173-177. PubMed ID: 27864108 [TBL] [Abstract][Full Text] [Related]
4. Evidence of perineural invasion on prostate biopsy specimen and survival after radical prostatectomy. DeLancey JO; Wood DP; He C; Montgomery JS; Weizer AZ; Miller DC; Jacobs BL; Montie JE; Hollenbeck BK; Skolarus TA Urology; 2013 Feb; 81(2):354-7. PubMed ID: 23374801 [TBL] [Abstract][Full Text] [Related]
5. Perineural invasion in prostate needle biopsy: Prognostic value on radical prostatectomy and active surveillance. Ramos N; Macedo A; Rosa J; Carvalho M Arch Ital Urol Androl; 2020 Dec; 92(4):. PubMed ID: 33348961 [TBL] [Abstract][Full Text] [Related]
6. The prognostic significance of perineural invasion and race in men considering active surveillance. Cohn JA; Dangle PP; Wang CE; Brendler CB; Novakovic KR; McGuire MS; Helfand BT BJU Int; 2014 Jul; 114(1):75-80. PubMed ID: 24106869 [TBL] [Abstract][Full Text] [Related]
7. Percent of prostate needle biopsy cores with cancer is significant independent predictor of prostate specific antigen recurrence following radical prostatectomy: results from SEARCH database. Freedland SJ; Aronson WJ; Terris MK; Kane CJ; Amling CL; Dorey F; Presti JC; J Urol; 2003 Jun; 169(6):2136-41. PubMed ID: 12771735 [TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of the diameter of perineural invasion in radical prostatectomy specimens. Maru N; Ohori M; Kattan MW; Scardino PT; Wheeler TM Hum Pathol; 2001 Aug; 32(8):828-33. PubMed ID: 11521227 [TBL] [Abstract][Full Text] [Related]
9. Perineural invasion detection in prostate biopsy is related to recurrence-free survival in patients submitted to radical prostatectomy. Katz B; Srougi M; Dall'Oglio M; Nesrallah AJ; Sant'anna AC; Pontes J; Antunes AA; Reis ST; Viana N; SaƱudo A; Camara-Lopes LH; Leite KR Urol Oncol; 2013 Feb; 31(2):175-9. PubMed ID: 21795075 [TBL] [Abstract][Full Text] [Related]
10. Population based study of predictors of adverse pathology among candidates for active surveillance with Gleason 6 prostate cancer. Vellekoop A; Loeb S; Folkvaljon Y; Stattin P J Urol; 2014 Feb; 191(2):350-7. PubMed ID: 24071481 [TBL] [Abstract][Full Text] [Related]
11. Can perineural invasion on prostate needle biopsy predict prostate specific antigen recurrence after radical prostatectomy? de la Taille A; Rubin MA; Bagiella E; Olsson CA; Buttyan R; Burchardt T; Knight C; O'Toole KM; Katz AE J Urol; 1999 Jul; 162(1):103-6. PubMed ID: 10379750 [TBL] [Abstract][Full Text] [Related]
12. Relationship and significance of greatest percentage of tumor and perineural invasion on needle biopsy in prostatic adenocarcinoma. Rubin MA; Bassily N; Sanda M; Montie J; Strawderman MS; Wojno K Am J Surg Pathol; 2000 Feb; 24(2):183-9. PubMed ID: 10680885 [TBL] [Abstract][Full Text] [Related]
13. Unilateral positive biopsies in low risk prostate cancer patients diagnosed with extended transrectal ultrasound-guided biopsy schemes do not predict unilateral prostate cancer at radical prostatectomy. Gallina A; Maccagnano C; Suardi N; Capitanio U; Abdollah F; Raber M; Salonia A; Scattoni V; Rigatti P; Montorsi F; Briganti A BJU Int; 2012 Jul; 110(2 Pt 2):E64-8. PubMed ID: 22093108 [TBL] [Abstract][Full Text] [Related]
14. Association of percent positive prostate biopsies and perineural invasion with biochemical outcome after external beam radiotherapy for localized prostate cancer. Wong WW; Schild SE; Vora SA; Halyard MY Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):24-9. PubMed ID: 15337536 [TBL] [Abstract][Full Text] [Related]
15. Perineural invasion as a predictor of biochemical outcome following radical prostatectomy for select men with clinically localized prostate cancer. D'Amico AV; Wu Y; Chen MH; Nash M; Renshaw AA; Richie JP J Urol; 2001 Jan; 165(1):126-9. PubMed ID: 11125380 [TBL] [Abstract][Full Text] [Related]
16. Limited value of perineural invasion in radical prostatectomy specimens as a predictor of biochemical recurrence in Japanese men with clinically localized prostate cancer. Miyake H; Sakai I; Harada K; Eto H; Hara I Hinyokika Kiyo; 2005 Apr; 51(4):241-6. PubMed ID: 15912782 [TBL] [Abstract][Full Text] [Related]
17. Expanded criteria to identify men eligible for active surveillance of low risk prostate cancer at Johns Hopkins: a preliminary analysis. Reese AC; Landis P; Han M; Epstein JI; Carter HB J Urol; 2013 Dec; 190(6):2033-8. PubMed ID: 23680308 [TBL] [Abstract][Full Text] [Related]
18. Pathologic prostate cancer characteristics in patients eligible for active surveillance: a head-to-head comparison of contemporary protocols. Iremashvili V; Pelaez L; Manoharan M; Jorda M; Rosenberg DL; Soloway MS Eur Urol; 2012 Sep; 62(3):462-8. PubMed ID: 22445138 [TBL] [Abstract][Full Text] [Related]
19. Can contemporary transrectal prostate biopsy accurately select candidates for hemi-ablative focal therapy of prostate cancer? Tareen B; Godoy G; Sankin A; Temkin S; Lepor H; Taneja SS BJU Int; 2009 Jul; 104(2):195-9. PubMed ID: 19191784 [TBL] [Abstract][Full Text] [Related]
20. Prostate cancer Ki-67 (MIB-1) expression, perineural invasion, and gleason score as biopsy-based predictors of prostate cancer mortality: the Mayo model. Tollefson MK; Karnes RJ; Kwon ED; Lohse CM; Rangel LJ; Mynderse LA; Cheville JC; Sebo TJ Mayo Clin Proc; 2014 Mar; 89(3):308-18. PubMed ID: 24486077 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]